Logo image of CSH.DE

CENIT AG (CSH.DE) Stock Fundamental Analysis

FRA:CSH - Deutsche Boerse Ag - DE0005407100 - Common Stock - Currency: EUR

8.3  +0.06 (+0.73%)

Fundamental Rating

3

Taking everything into account, CSH scores 3 out of 10 in our fundamental rating. CSH was compared to 103 industry peers in the Software industry. CSH has a bad profitability rating. Also its financial health evaluation is rather negative. CSH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CSH has reported negative net income.
In the past year CSH had a positive cash flow from operations.
CSH had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CSH had a positive operating cash flow.
CSH.DE Yearly Net Income VS EBIT VS OCF VS FCFCSH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

1.2 Ratios

With a Return On Assets value of -2.91%, CSH is not doing good in the industry: 61.39% of the companies in the same industry are doing better.
CSH has a worse Return On Equity (-13.41%) than 65.35% of its industry peers.
The Return On Invested Capital of CSH (0.35%) is comparable to the rest of the industry.
CSH had an Average Return On Invested Capital over the past 3 years of 3.71%. This is significantly below the industry average of 10.93%.
Industry RankSector Rank
ROA -2.91%
ROE -13.41%
ROIC 0.35%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
CSH.DE Yearly ROA, ROE, ROICCSH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

The Operating Margin of CSH (0.34%) is comparable to the rest of the industry.
CSH's Operating Margin has declined in the last couple of years.
The Gross Margin of CSH (59.34%) is worse than 60.40% of its industry peers.
CSH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.34%
PM (TTM) N/A
GM 59.34%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
CSH.DE Yearly Profit, Operating, Gross MarginsCSH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CSH is destroying value.
Compared to 1 year ago, CSH has about the same amount of shares outstanding.
CSH has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, CSH has a worse debt to assets ratio.
CSH.DE Yearly Shares OutstandingCSH.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CSH.DE Yearly Total Debt VS Total AssetsCSH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

CSH has an Altman-Z score of 1.93. This is not the best score and indicates that CSH is in the grey zone with still only limited risk for bankruptcy at the moment.
CSH's Altman-Z score of 1.93 is in line compared to the rest of the industry. CSH outperforms 44.55% of its industry peers.
The Debt to FCF ratio of CSH is 6.47, which is on the high side as it means it would take CSH, 6.47 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.47, CSH is in line with its industry, outperforming 57.43% of the companies in the same industry.
A Debt/Equity ratio of 1.27 is on the high side and indicates that CSH has dependencies on debt financing.
The Debt to Equity ratio of CSH (1.27) is worse than 78.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 6.47
Altman-Z 1.93
ROIC/WACC0.05
WACC6.86%
CSH.DE Yearly LT Debt VS Equity VS FCFCSH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.27 indicates that CSH should not have too much problems paying its short term obligations.
CSH has a Current ratio (1.27) which is in line with its industry peers.
A Quick Ratio of 1.27 indicates that CSH should not have too much problems paying its short term obligations.
CSH has a Quick ratio of 1.27. This is comparable to the rest of the industry: CSH outperforms 52.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
CSH.DE Yearly Current Assets VS Current LiabilitesCSH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

The earnings per share for CSH have decreased strongly by -202.55% in the last year.
The Revenue has grown by 8.57% in the past year. This is quite good.
CSH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.84% yearly.
EPS 1Y (TTM)-202.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17693.75%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%1.91%

3.2 Future

CSH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 57.91% yearly.
CSH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.43% yearly.
EPS Next Y37.5%
EPS Next 2Y57.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.91%
Revenue Next 2Y7.35%
Revenue Next 3Y5.86%
Revenue Next 5Y4.43%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CSH.DE Yearly Revenue VS EstimatesCSH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M 250M
CSH.DE Yearly EPS VS EstimatesCSH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSH. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 8.67, the valuation of CSH can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CSH is valued cheaper than 94.06% of the companies in the same industry.
CSH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.76.
Industry RankSector Rank
PE N/A
Fwd PE 8.67
CSH.DE Price Earnings VS Forward Price EarningsCSH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

89.11% of the companies in the same industry are more expensive than CSH, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CSH is valued cheaply inside the industry as 94.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.84
EV/EBITDA 7.95
CSH.DE Per share dataCSH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSH's earnings are expected to grow with 57.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.91%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CSH!.
Industry RankSector Rank
Dividend Yield N/A

CENIT AG

FRA:CSH (7/11/2025, 7:00:00 PM)

8.3

+0.06 (+0.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-14 2025-05-14
Earnings (Next)08-01 2025-08-01
Inst Owners52.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap69.47M
Analysts88.89
Price Target16.44 (98.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.04
Dividend Growth(5Y)-41.82%
DP-6.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.03%
PT rev (3m)-3.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.67
P/S 0.33
P/FCF 8.84
P/OCF 7.35
P/B 1.94
P/tB N/A
EV/EBITDA 7.95
EPS(TTM)-0.57
EYN/A
EPS(NY)0.96
Fwd EY11.53%
FCF(TTM)0.94
FCFY11.31%
OCF(TTM)1.13
OCFY13.61%
SpS24.89
BVpS4.28
TBVpS-3.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.91%
ROE -13.41%
ROCE 0.72%
ROIC 0.35%
ROICexc 0.48%
ROICexgc 4.96%
OM 0.34%
PM (TTM) N/A
GM 59.34%
FCFM 3.77%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
ROICexc(3y)4.78%
ROICexc(5y)6.49%
ROICexgc(3y)14.59%
ROICexgc(5y)14.62%
ROCE(3y)8.58%
ROCE(5y)8.95%
ROICexcg growth 3Y-6.55%
ROICexcg growth 5Y-5.33%
ROICexc growth 3Y-30.45%
ROICexc growth 5Y-21.57%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
F-Score4
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 6.47
Debt/EBITDA 3.91
Cap/Depr 14.57%
Cap/Sales 0.77%
Interest Coverage 0.25
Cash Conversion 80.98%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 1.93
F-Score4
WACC6.86%
ROIC/WACC0.05
Cap/Depr(3y)19.26%
Cap/Depr(5y)16.81%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-202.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17693.75%
EPS Next Y37.5%
EPS Next 2Y57.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.57%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%1.91%
Revenue Next Year9.91%
Revenue Next 2Y7.35%
Revenue Next 3Y5.86%
Revenue Next 5Y4.43%
EBIT growth 1Y-93.22%
EBIT growth 3Y3.24%
EBIT growth 5Y-5.88%
EBIT Next Year139.79%
EBIT Next 3Y51.43%
EBIT Next 5Y30.03%
FCF growth 1Y6.46%
FCF growth 3Y5.1%
FCF growth 5Y-0.8%
OCF growth 1Y5.25%
OCF growth 3Y7.86%
OCF growth 5Y-2.42%